ERYTECH to Present Preclinical and Clinical Data on Use of Eryaspase in ALL and AML at EHA 2018
June 15, 2018 01:30 ET
|
Erytech Pharma S.A.
LYON, France, June 15, 2018 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext:ERYP) (Nasdaq:ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic...
ERYTECH to Webcast Presentation at the Jefferies Global Healthcare Conference
May 30, 2018 01:30 ET
|
Erytech Pharma S.A.
LYON, France, May 30, 2018 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext Paris:ERYP) (Nasdaq:ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating...
ERYTECH Reports First Quarter 2018 Financial Results and Provides Business Update
May 14, 2018 16:30 ET
|
Erytech Pharma S.A.
Finalized Phase 3 trial design for eryaspase in second line pancreatic cancer; on track for expected start of patient enrollment in Q3Selected triple-negative breast cancer as the next solid tumor...
ERYTECH annonce le dépôt de son Document de Référence 2017 et de son Form 20-F 2017
April 24, 2018 16:30 ET
|
Erytech Pharma S.A.
LYON, France, 24 avr. 2018 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext Paris:ERYP) (Nasdaq:ERYP), société biopharmaceutique de stade clinique développant à partir de sa plateforme propriétaire...
ERYTECH Announces Filing of 2017 “Document de Référence” and 2017 Annual Report on Form 20-F
April 24, 2018 16:30 ET
|
Erytech Pharma S.A.
LYON, France, April 24, 2018 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext Paris:ERYP) (Nasdaq:ERYP), the clinical-stage biopharmaceutical company developing innovative therapies for severe forms of...
Carcinoembryonic Antigen Market to hit $2.7bn by 2023: Global Market Insights, Inc.
April 20, 2017 06:30 ET
|
Global Market Insights, Inc
Ocean View, Delaware, April 20, 2017 (GLOBE NEWSWIRE) -- The research report “Carcinoembryonic Antigen (CEA) Market Size By Application (Colorectal, Pancreatic, Ovarian, Breast, Thyroid Cancer),...
Carcinoembryonic antigen (CEA) market size worth $2.78 Billion by 2023: Global Market Insights Inc.
May 16, 2016 07:30 ET
|
Global Market Insights, Inc
Dover, DE, May 16, 2016 (GLOBE NEWSWIRE) -- Carcinoembryonic antigen (CEA) market size is forecast to reach USD 2.78 billion by 2023; as reported in the latest study by Global Market Insights,...
OncoMed to Present at Upcoming Investment Conferences
May 28, 2015 16:30 ET
|
OncoMed Pharmaceuticals, Inc.
REDWOOD CITY, Calif., May 28, 2015 (GLOBE NEWSWIRE) -- OncoMed Pharmaceuticals, Inc. (Nasdaq:OMED), a clinical-stage company developing novel therapeutics that target cancer stem cell (CSC) and...